IBDEI15C ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19149,0)
 ;;=B20.^^94^918^31
 ;;^UTILITY(U,$J,358.3,19149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19149,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,19149,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,19149,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,19150,0)
 ;;=B02.9^^94^918^93
 ;;^UTILITY(U,$J,358.3,19150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19150,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,19150,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,19150,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,19151,0)
 ;;=A60.9^^94^918^2
 ;;^UTILITY(U,$J,358.3,19151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19151,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,19151,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,19151,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,19152,0)
 ;;=A60.04^^94^918^34
 ;;^UTILITY(U,$J,358.3,19152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19152,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,19152,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,19152,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,19153,0)
 ;;=A60.01^^94^918^32
 ;;^UTILITY(U,$J,358.3,19153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19153,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,19153,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=B00.1^^94^918^33
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19154,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,19154,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,19154,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,19155,0)
 ;;=B97.89^^94^918^89
 ;;^UTILITY(U,$J,358.3,19155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19155,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,19155,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=B97.10^^94^918^21
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19156,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,19156,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=B34.9^^94^918^90
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19157,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,19157,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=A69.20^^94^918^50
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19158,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,19158,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=A69.22^^94^918^52
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19159,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,19159,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=A69.21^^94^918^51
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19160,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,19160,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=A69.29^^94^918^18
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19161,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,19161,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,19161,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=A69.23^^94^918^5
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^4^2
